Israeli researchers have developed a combined mRNA vaccine targeting Yersinia pestis, the bacterium responsible for the plague. In preclinical trials, the vaccine demonstrated high efficacy in protecting mice from the disease.
Both molecules transmit genetic information and consist of nucleic acids, but their different chemical properties greatly affect their biological functions.
4 minutes 
